Entering text into the input field will update the search result below

Cannara Biotech reports Q4 results

Dec. 08, 2021 8:22 AM ETCannara Biotech Inc. (LOVFF), LOVE:CABy: Meghavi Singh, SA News Editor
  • Cannara Biotech (OTCQB:LOVFF): Q4 GAAP EPS of C$0.01.
  • Revenue of C$6.48M (+962.3% Y/Y)
  • Press Release
  • Looking ahead, the company expects to optimize the additional debt financing from CIBC to finalize the redesign of several zones at the Valleyfield Facility to replicate

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.